Ieq Capital LLC acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 19,874 shares of the company’s stock, valued at approximately $355,000.
Other large investors have also recently made changes to their positions in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Grail in the fourth quarter valued at approximately $244,000. Moloney Securities Asset Management LLC purchased a new position in shares of Grail during the 4th quarter worth approximately $559,000. Wesbanco Bank Inc. bought a new stake in shares of Grail during the 4th quarter valued at $523,000. Slow Capital Inc. purchased a new stake in shares of Grail in the 4th quarter worth about $2,379,000. Finally, abrdn plc bought a new stake in shares of Grail in the 4th quarter worth approximately $3,768,000.
Analyst Upgrades and Downgrades
Several analysts have commented on the company. Morgan Stanley began coverage on Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They issued a “peer perform” rating on the stock.
Grail Stock Performance
Shares of GRAL stock opened at $39.28 on Friday. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The company’s fifty day moving average price is $28.49 and its 200-day moving average price is $19.94.
Grail (NASDAQ:GRAL – Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. Equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.
Grail Profile
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Read More
- Five stocks we like better than Grail
- How to Use the MarketBeat Dividend Calculator
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to Read Stock Charts for Beginners
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- 3 Monster Growth Stocks to Buy Now
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL – Free Report).
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.
